Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $29.78 in the prior trading day, Axogen Inc (NASDAQ: AXGN) closed at $29.35, down -1.44%. In other words, the price has decreased by -$1.44 from its previous closing price. On the day, 0.82 million shares were traded. AXGN stock price reached its highest trading level at $30.035 during the session, while it also had its lowest trading level at $28.98.
Ratios:
Our goal is to gain a better understanding of AXGN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 34.02 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 405.30. For the most recent quarter (mrq), Quick Ratio is recorded 2.64 and its Current Ratio is at 4.09. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.54.
Upgrades & Downgrades
In the most recent recommendation for this company, Mizuho on December 01, 2025, initiated with a Outperform rating and assigned the stock a target price of $40.
On March 17, 2025, Lake Street started tracking the stock assigning a Buy rating and target price of $30. On July 01, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $13.Raymond James initiated its Outperform rating on July 01, 2024, with a $13 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 16 ’25 when Amy McBride-Wendell bought 43,684 shares for $29.31 per share.
KATHY WEILER bought 46,653 shares of AXGN for $1,378,484 on Dec 16 ’25. On Dec 15 ’25, another insider, LINDSEY MARIE HARTLEY, who serves as the Officer of the company, bought 14,812 shares for $29.86 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AXGN now has a Market Capitalization of 1353689216 and an Enterprise Value of 1387680128. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.75. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.30 while its Price-to-Book (P/B) ratio in mrq is 11.20. Its current Enterprise Value per Revenue stands at 6.463 whereas that against EBITDA is 127.439.
Stock Price History:
The Beta on a monthly basis for AXGN is 1.01, which has changed by 1.0767086 over the last 52 weeks, in comparison to a change of 0.16081822 over the same period for the S&P500. Over the past 52 weeks, AXGN has reached a high of $34.24, while it has fallen to a 52-week low of $9.22. The 50-Day Moving Average of the stock is 24.56%, while the 200-Day Moving Average is calculated to be 75.23%.
Shares Statistics:
The stock has traded on average 911.31K shares per day over the past 3-months and 1126710 shares per day over the last 10 days, according to various share statistics. A total of 46.12M shares are outstanding, with a floating share count of 44.84M. Insiders hold about 2.78% of the company’s shares, while institutions hold 89.97% stake in the company. Shares short for AXGN as of 1764288000 were 2849251 with a Short Ratio of 3.13, compared to 1761868800 on 2733034. Therefore, it implies a Short% of Shares Outstanding of 2849251 and a Short% of Float of 6.36.
Earnings Estimates
The performance of Axogen Inc (AXGN) in the stock market is under the watchful eye of 6.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is $0.07, with high estimates of $0.1 and low estimates of $0.01.
Analysts are recommending an EPS of between $0.35 and $0.27 for the fiscal current year, implying an average EPS of $0.29. EPS for the following year is $0.5, with 6.0 analysts recommending between $0.63 and $0.43.
Revenue Estimates
9 analysts predict $58M in revenue for. The current quarter. It ranges from a high estimate of $59.8M to a low estimate of $57.5M. As of. The current estimate, Axogen Inc’s year-ago sales were $49.41MFor the next quarter, 9 analysts are estimating revenue of $57.24M. There is a high estimate of $60M for the next quarter, whereas the lowest estimate is $55.6M.
A total of 9 analysts have provided revenue estimates for AXGN’s current fiscal year. The highest revenue estimate was $225.1M, while the lowest revenue estimate was $222.8M, resulting in an average revenue estimate of $223.3M. In the same quarter a year ago, actual revenue was $187.34MBased on 9 analysts’ estimates, the company’s revenue will be $258.08M in the next fiscal year. The high estimate is $262.7M and the low estimate is $251M.
